Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
Securon IV.
| Pharmaceutical Form |
|---|
|
Aqueous solution for intravenous injection. |
Verapamil Hydrochloride BP 2.5 mg/ml.
| Active Ingredient | Description | |
|---|---|---|
| Verapamil |
Verapamil is a phenylalkylamine calcium antagonist which blocks the inward movement of calcium ions in cardiac muscle cells, in smooth muscle cells of the coronary and systemic arteries and in cells of the intracardiac conduction system. It lowers heart rate, increases myocardial perfusion and reduces coronary spasm. Because of its effect on the movement of calcium in the intracardiac conduction system, verapamil reduces automaticity, decreases conduction velocity and increases the refractory period. |
| List of Excipients |
|---|
|
Water for injections |
2 ml glass ampoule (hydrolytic type 1) containing 5 mg verapamil.
Pack size: 5 × 2 ml ampoules.
Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
PL 46302/0026
17 June 2003
| Drug | Countries | |
|---|---|---|
| SECURON | Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
